Short Interest in AquaBounty Technologies, Inc. (NASDAQ:AQB) Expands By 452.6%

AquaBounty Technologies, Inc. (NASDAQ:AQB) saw a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 423,300 shares, an increase of 452.6% from the December 31st total of 76,600 shares. Approximately 11.7% of the shares of the company are short sold. Based on an average daily trading volume, of 425,500 shares, the days-to-cover ratio is currently 1.0 days.

AquaBounty Technologies Stock Performance

NASDAQ:AQB opened at $0.70 on Wednesday. The company has a fifty day moving average of $0.80 and a two-hundred day moving average of $1.07. AquaBounty Technologies has a fifty-two week low of $0.47 and a fifty-two week high of $2.79. The stock has a market capitalization of $2.71 million, a PE ratio of -0.04 and a beta of 1.17. The company has a debt-to-equity ratio of 0.05, a quick ratio of 2.98 and a current ratio of 3.02.

AquaBounty Technologies (NASDAQ:AQB) last posted its quarterly earnings data on Tuesday, November 5th. The company reported ($0.88) EPS for the quarter, hitting the consensus estimate of ($0.88). The company had revenue of $0.05 million during the quarter, compared to analyst estimates of $0.10 million. AquaBounty Technologies had a negative return on equity of 18.20% and a negative net margin of 5,842.69%. During the same period in the previous year, the business earned ($1.60) EPS.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in AquaBounty Technologies stock. Epiq Partners LLC increased its position in shares of AquaBounty Technologies, Inc. (NASDAQ:AQB) by 423.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 89,000 shares of the company’s stock after purchasing an additional 72,000 shares during the period. Epiq Partners LLC owned 2.30% of AquaBounty Technologies worth $56,000 at the end of the most recent quarter. Institutional investors own 8.92% of the company’s stock.

About AquaBounty Technologies

AquaBounty Technologies, Inc, a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.